E. Sugiyama

发表

A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

C. Sotozono, M. Muramatsu, J. Nishikawa, 2011, The Pharmacogenomics Journal.

Identification of a predictive biomarker for hematologic toxicities of gemcitabine.

H. Ueno, Tesshi Yamada, S. Hirohashi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thirty novel genetic variations in the SLC29A1 gene encoding human equilibrative nucleoside transporter 1 (hENT1).

H. Ueno, Teruhiko Yoshida, N. Saijo, 2006, Drug metabolism and pharmacokinetics.

Substrate-Dependent Functional Alterations of Seven CYP2C9 Variants Found in Japanese Subjects

T. Miyata, Yoshiro Saito, K. Yasuda, 2009, Drug Metabolism and Disposition.

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development.

Yoshiro Saito, K. Kurose, E. Sugiyama, 2012, Drug metabolism and pharmacokinetics.

Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.

H. Ueno, Teruhiko Yoshida, N. Saijo, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

H. Ueno, Teruhiko Yoshida, N. Saijo, 2005, Clinical Cancer Research.

found in Japanese subjects

T. Miyata, Yoshiro Saito, K. Yasuda, 2009 .

Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients

H. Ueno, Teruhiko Yoshida, N. Saijo, 2010, Clinical pharmacokinetics.

IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.

A. Sekine, T. Mushiroda, M. Kubo, 2015, The Journal of allergy and clinical immunology.

Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement

C. Sotozono, M. Muramatsu, K. Tokunaga, 2014, Scientific Reports.

Drugs causing severe ocular surface involvements in Japanese patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.

C. Sotozono, Yoshiro Saito, Z. Ikezawa, 2015, Allergology international : official journal of the Japanese Society of Allergology.

Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene.

N. Kamatani, Yoshiro Saito, M. Tohkin, 2009, Drug metabolism and pharmacokinetics.

Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects.

T. Mushiroda, M. Kubo, C. Sotozono, 2013, Pharmacogenomics.

Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment*

Yoshiro Saito, Hideki Ueno, Koh Furuta, 2010, Molecular & Cellular Proteomics.

A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies

N. Laird, H. Ueno, N. Saijo, 2009, The Pharmacogenomics Journal.

Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK).

H. Ueno, Teruhiko Yoshida, N. Saijo, 2008, Drug metabolism and pharmacokinetics.

Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese.

T. Kitamoto, A. Sekine, C. Sotozono, 2015, Pharmacogenomics.

Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in Japanese.

J. Nishikawa, Yoshiro Saito, M. Tohkin, 2012, Drug metabolism and pharmacokinetics.

Structural significance of residues 158-160 in the H3N2 hemagglutnin globular head: A computational study with implications in viral evolution and infection.

E. Sugiyama, M. Cueno, K. Imai, 2019, Journal of molecular graphics & modelling.

Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

H. Ueno, N. Saijo, M. Ikeda, 2009, British Journal of Cancer.

Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients.

Teruhiko Yoshida, N. Saijo, Y. Ohe, 2009, Drug Metabolism and Pharmacokinetics.